What Causes Acute Enteritis and How Is It Treated?

Acute enteritis is inflammation of the small intestine that comes on suddenly, almost always triggered by an infection, and typically resolves within days. The hallmark symptoms are watery diarrhea, abdominal cramps, nausea, and sometimes fever or vomiting. Most cases are caused by viruses or bacteria picked up through contaminated food or water, though toxins and even medical treatments like radiation can produce the same gut inflammation. While the illness is usually self-limiting, it remains a significant cause of hospitalization worldwide, and its consequences can extend well beyond the initial bout of diarrhea.

Common Causes

The vast majority of acute enteritis cases are infectious. Viruses, especially rotavirus and norovirus, are the leading culprits in young children and in institutional outbreaks. Bacteria like Campylobacter, Salmonella, and Shigella are responsible for much of the foodborne illness seen in adults. Campylobacter jejuni and Campylobacter coli, for example, colonize the intestinal lining and trigger acute inflammatory diarrhea by provoking a strong immune response in the gut wall.

Staphylococcus aureus enterotoxins represent a somewhat different route to the same symptoms. Rather than the bacteria themselves infecting the gut, pre-formed toxins in contaminated food, particularly processed meat and dairy products handled improperly or stored at warm temperatures, cause rapid-onset nausea and violent vomiting, sometimes with diarrhea. The illness is typically self-limiting and only occasionally severe enough to require hospital care.1PubMed Central. Food poisoning and Staphylococcus aureus enterotoxins

Non-infectious causes deserve mention too. Radiation therapy for abdominal or pelvic cancers can produce acute radiation enteritis, damaging the intestinal lining and causing bloody stool and significant inflammation. Animal studies have shown that this type of enteritis involves surges in inflammatory markers like tumor necrosis factor-α and interleukins, along with increased oxidative stress and cell death in the gut.2PubMed. Rheinic acid ameliorates radiation-induced acute enteritis in rats through PPAR-γ/NF-κB Certain medications, food allergies, and autoimmune reactions can also inflame the small intestine acutely, though infectious causes dominate in everyday clinical practice.

What Happens Inside the Gut

Under normal conditions, the intestinal lining acts as both a selective barrier and a finely tuned water-management system. The cells that line the intestine absorb the enormous volume of fluid that passes through each day, keeping absorption ahead of secretion. When a pathogen invades, this balance tips. In secretory diarrhea, chloride secretion by intestinal cells ramps up and overwhelms the absorptive capacity, pulling water into the gut lumen and producing the watery stools that define the illness.3PubMed Central. Intestinal secretory mechanisms and diarrhea

At the same time, the infection disrupts the physical barrier between the gut contents and the body’s deeper tissues. The tight junctions and adherens junctions that normally seal neighboring intestinal cells together become compromised during inflammation, increasing permeability. This “leaky” barrier lets bacterial products and immune-stimulating molecules cross into the tissue below, amplifying the inflammatory response. In the case of Campylobacter, the bacteria actively provoke the intestinal cells to release the inflammatory signal interleukin-8, recruiting immune cells to the site and escalating the inflammation regardless of how efficiently the bacteria themselves invade.4PubMed Central. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB

Distinguishing Bacterial From Viral Infections

From the patient’s perspective, bacterial and viral enteritis can look very similar: both cause diarrhea, cramps, and malaise. But the distinction matters for treatment, because antibiotics are useless against viruses and overusing them breeds resistance. One of the more promising tools for sorting cases without waiting days for stool cultures is fecal calprotectin, a protein released by white blood cells migrating into the gut during inflammation.

In children with acute gastroenteritis, fecal calprotectin levels are dramatically higher in bacterial infections. One study found that children with positive stool cultures had a median calprotectin of about 1,870 mg/L, compared with roughly 95 mg/L in children with viral infections.5The American Journal of Emergency Medicine. Fecal calprotectin: can be used to distinguish between bacterial and viral gastroenteritis in children? Another study reported that calprotectin reached a diagnostic accuracy of about 92% for identifying bacterial cases, with sensitivity of 93% and specificity of 88% at an appropriate cutoff.6PubMed. Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis Calprotectin patterns also track with specific bacteria: Salmonella and Campylobacter infections produce median levels in the range of roughly 690 to 765 μg/g, while rotavirus, norovirus, and adenovirus infections cluster around 89 to 95 μg/g.7PubMed. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children

Multiplex PCR panels, which test for dozens of pathogens in a single stool sample, have also changed the diagnostic landscape. These panels pick up far more infections than traditional stool cultures: in one large comparison, the PCR panel was positive in about 29% of samples versus just 4% with conventional testing.8PubMed Central. Impact of Gastrointestinal Panel Implementation on Health Care Utilization and Outcomes Faster, more specific results translate into real changes in care. When PCR results are available, antibiotic use drops: in pediatric cases, antibiotics were started in about 41% of confirmed bacterial infections but in none of the pathogen-negative cases, and antibiotics were discontinued more often when a viral cause was confirmed.9PubMed Central. Impact of gastrointestinal multiplex PCR on the diagnosis, clinical correlation, and antimicrobial stewardship in pediatric acute gastroenteritis Patients tested with PCR panels also underwent fewer endoscopies and fewer abdominal imaging studies, likely because clinicians felt more confident in the diagnosis.10PubMed Central. Impact of Gastrointestinal Panel Implementation on Health Care Utilization and Outcomes

Treatment and When Antibiotics Actually Help

For most people with acute enteritis, the cornerstone of treatment is replacing lost fluid and electrolytes rather than attacking the pathogen directly. Oral rehydration solution works because of a clever piece of gut biology: the sodium/glucose cotransporter in the intestinal lining couples the absorption of sodium and glucose together, and water follows along. Research has shown that roughly 260 water molecules are directly coupled to each sugar molecule transported through this pathway, accounting for an estimated five liters of water absorption per day in the human intestine.11PubMed Central. Cotransport of water by the Na+/glucose cotransporter This is why drinking plain water during severe diarrhea is far less effective than an ORS with the right balance of sodium and glucose: you need both to activate the transporter that pulls water across the gut wall.

Antibiotics, meanwhile, are genuinely unhelpful in most cases and can cause harm by disrupting gut bacteria further. The Infectious Diseases Society of America’s guidelines are clear: in people with healthy immune systems who have acute watery diarrhea and no recent international travel, empiric antibiotics are not recommended. Even for bloody diarrhea, the guidelines advise against routine empiric antibiotics while awaiting test results, with a few specific exceptions. Those exceptions include infants under three months where a bacterial cause is suspected, people with high fever, abdominal pain, and frequent bloody stools suggestive of Shigella dysentery, and travelers with fever above 38.5°C or signs of sepsis. When empiric therapy is warranted in adults, a fluoroquinolone or azithromycin is typically chosen based on local resistance patterns.12Infectious Diseases Society of America. IDSA 2017 Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea – Section: Empiric Management of Infectious Diarrhea

The evidence on probiotics for acute gastroenteritis is underwhelming. A systematic review of clinical trials found that while probiotics showed benefits in some chronic inflammatory bowel conditions and antibiotic-associated diarrhea, about a fifth of the included studies showed no effectiveness, and the evidence for acute infectious gastroenteritis specifically was mixed.13PubMed Central. Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical Trials Probiotics are generally safe, but their role in shortening an acute episode remains uncertain enough that guidelines have not adopted them as standard care.

Dehydration Risks in Children and Older Adults

The danger of acute enteritis lies less in the infection itself than in the fluid loss it causes, particularly at the extremes of age. Young children lose water faster relative to their body weight, and they are less able to communicate thirst or regulate their own intake. Validated dehydration scoring systems used in emergency departments illustrate the stakes: children rated as moderately to severely dehydrated had an average emergency department stay of roughly eight hours, compared with about four hours for those with no dehydration. The moderately to severely dehydrated group also had far higher rates of intravenous fluid treatment.14Pediatrics. Validation of the Clinical Dehydration Scale for Children With Acute Gastroenteritis External validation of the same scoring tool confirmed these patterns, with median time in the emergency department climbing from under an hour in mild cases to over seven hours in severe dehydration.15PubMed. External validation of the clinical dehydration scale for children with acute gastroenteritis

Older adults face different but equally serious risks. The immune system weakens with age, making elderly patients vulnerable to pathogens that rarely trouble younger people. Cytomegalovirus enteritis, for example, is rare in people with healthy immune systems but can cause massive intestinal bleeding in older patients, likely because aging brings a degree of immune decline that allows the virus to reactivate.16PubMed Central. CMV enteritis causing massive intestinal hemorrhage in an elderly patient Older adults are also more likely to be taking medications that mask symptoms or complicate fluid balance, making dehydration harder to recognize before it becomes dangerous.

Post-Infectious Irritable Bowel Syndrome

One of the more frustrating consequences of acute enteritis is that the infection can resolve, the pathogen can be cleared, and yet symptoms persist for months or years. This condition, called post-infectious irritable bowel syndrome, affects a meaningful fraction of people after a bout of infectious enteritis. A large systematic review and meta-analysis identified several factors that raise the risk: being female roughly doubled the odds, antibiotic use during the acute illness increased the odds by about 70%, and psychological factors like anxiety, depression, and especially somatization were strongly linked, with somatization carrying more than a fourfold increase in risk. The severity of the initial enteritis episode also predicted who would go on to develop lasting symptoms.17PubMed Central. Prevalence, Risk Factors, and Outcomes of Irritable bowel Syndrome After Infectious Enteritis: a Systematic Review and Meta-analysis

The mechanisms are not fully pinned down, but persistent low-grade inflammation, increased intestinal permeability, and shifts in gut bacteria all appear to play a role.18PubMed Central. Post-infectious irritable bowel syndrome The finding that antibiotic exposure during the acute illness itself raises the risk of later IBS is particularly interesting, because it suggests that the drugs intended to help may sometimes prolong the disruption by further destabilizing the microbial community in the gut. This adds another reason to the argument against reflexive antibiotic use for enteritis.

Reactive Arthritis After Gut Infections

Beyond the gut, certain enteric infections can trigger joint inflammation weeks after the diarrhea has stopped. Reactive arthritis, sometimes called Reiter syndrome, is an inflammatory joint condition that develops in response to an infection elsewhere in the body. It is most commonly associated with Campylobacter and Shigella enteritis. A systematic review estimated that reactive arthritis occurs in roughly 1 to 5% of people infected with Campylobacter, with an annual incidence of about 4.3 per 100,000 people after Campylobacter and 1.3 per 100,000 after Shigella.19PubMed Central. Campylobacter Reactive Arthritis: A Systematic Review The arthritis typically affects large joints like knees and ankles, and while it usually resolves within months, some people develop chronic joint problems. Genetic factors, particularly certain tissue-compatibility markers, influence who is susceptible.

Microbiome Disruption and How Long Recovery Takes

Even after the acute symptoms pass and the pathogen is gone, the gut’s microbial community can remain altered for weeks. A study following patients after Campylobacter enteritis found that two months after infection, their gut bacteria were still significantly less diverse than those of matched healthy controls. The patients showed reduced levels of Firmicutes, particularly in the Clostridiales order and the Ruminococcaceae family, along with increased levels of Proteobacteria, Fusobacteria, and Gammaproteobacteria.20Gut. Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery These are not just abstract bacterial name changes: the Firmicutes groups that were depleted are key producers of short-chain fatty acids that nourish the intestinal lining and regulate inflammation. Their loss may help explain why some patients continue to experience bloating, irregular bowel habits, or abdominal discomfort long after the acute infection has cleared.

The impaired microbiome recovery also connects to the post-infectious IBS risk described above. Evidence supports the idea that pathogen-driven modifications to the resident gut bacteria, combined with lingering changes in barrier integrity and immune function, create the conditions for ongoing digestive symptoms even without any continuing infection.21PubMed Central. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection

Why Some People Resist Certain Infections

Not everyone exposed to the same pathogen gets sick, and for at least one major cause of enteritis, the reason is partly genetic. Susceptibility to norovirus, one of the most common causes of acute gastroenteritis worldwide, depends heavily on whether a person expresses certain sugar molecules called histo-blood group antigens on the surface of their intestinal cells. These molecules are controlled by the FUT2 gene, often called the “secretor” gene. People who carry two inactive copies of FUT2, known as non-secretors, do not express these surface sugars and are resistant to several norovirus genotypes, including GII.4, the strain responsible for the majority of outbreaks globally.22PubMed Central. Genetic Susceptibility to Human Norovirus Infection: An Update

About 20% of people of European descent are non-secretors, which means a substantial minority of the population has built-in protection against the dominant norovirus strains. This does not make them immune to all gastroenteritis, of course, as plenty of other viruses and bacteria can still cause illness. But it does explain why, during a norovirus outbreak, some household members get violently ill while others sharing the same food and space walk away without a single symptom. The virus simply cannot latch onto their gut cells.

Rotavirus Vaccination and Its Measurable Impact

Of all the infectious causes of acute enteritis, rotavirus has been the most amenable to prevention through vaccination. Before vaccines were introduced, rotavirus was the leading cause of severe dehydrating diarrhea in children under five worldwide. The impact of vaccination programs has been substantial and well documented. A global analysis found that in countries that adopted the vaccine, hospitalizations and emergency visits for all-cause acute gastroenteritis in children under five dropped by a median of 38%, while hospitalizations specifically due to confirmed rotavirus fell by a median of 67%.23The Journal of Infectious Diseases. Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality From Diarrhea

Brazil offers a particularly clear case study, having introduced the vaccine nationally in 2006. Over the following twelve years, diarrhea hospitalization rates in children under five fell by more than 50%, and diarrhea mortality declined significantly as well.24PubMed. Impact of a twelve-year rotavirus vaccine program on acute diarrhea mortality and hospitalization in Brazil: 2006-2018 The benefits extended beyond just the vaccinated children themselves, since reducing rotavirus transmission in young children also lowers exposure for older siblings, parents, and grandparents. This herd effect is one reason why all-cause gastroenteritis admissions fell, not just the rotavirus-specific ones.

For a disease that most people dismiss as “just a stomach bug,” the cumulative toll of acute enteritis is surprisingly high. The combination of effective vaccines, smarter diagnostic tools, and more disciplined antibiotic use has already begun to shift that burden, but the gap between what we know and how we routinely manage these infections remains wide in many healthcare settings.